Abstract
The purpose was to ascertain if any relation exists between the elevated intraocular pressure (IOP) in patients with thyroid-associated orbitopathy (TAO) in active stage and the severity of extraocular muscle involvement and the extent of exophthalmos.
Methods
A total of 96 eyes and orbits of 48 adult patients with active TAO were investigated. All patients underwent magnetic resonance imaging of the orbit and measurement of all extraocular recti muscles (EOM). The obtained data was divided into two groups according to the IOP value: normal IOP ≤ 21 mmHg; n = 47 and elevated IOP with IOP > 21 mmHg; n = 49, and analyszed.
Results
A significant difference was found in the short diameter of medial rectus and inferior rectus muscles and in the sum of short parameters of all EOM. All these parameters were significantly higher in the elevated IOP group. Motility restriction in at least one gaze direction was also significantly more frequent (p < 0.0001) in the elevated IOP group. A positive moderate correlation was found between IOP and the sum of short parameters of EOM (r = 0.496). No correlation was found between the IOP and exophthalmos values (r = 0.267). During the follow-up, the frequency of strabismus surgery and orbital decompression was significantly higher in the elevated IOP group (p = 0.003; p = 0.002).
Conclusion
Elevated IOP in the active TAO stage particularly correlates with extraocular muscle involvement. These patients are also more likely to require orbital decompression and strabismus surgery.
Similar content being viewed by others
References
Wessely K (1918) Discussion of Hertel E. Der Dtsch Ophthlmol Ges 41:80–81
Ohtsuka K, Nakamura Y (2000) Open-angle glaucoma associated with Graves disease. Am J Ophthalmol 129(5):613–617
Behrouzi Z, Rabei HM, Azizi F, Daftarian N, Mehrabi Y, Ardeshiri M, Mohammadpour M (2007) Prevalence of open-angle glaucoma, glaucoma suspect, and ocular hypertension in thyroid-related immune orbitopathy. J Glaucoma 16(4):358–362
Cockerham KP, Pal C, Jani B, Wolter A, Kennerdell JS (1997) The prevalence and implications of ocular hypertension and glaucoma in thyroid-associated orbitopathy. Ophthalmology 104(6):914–917
Kalmann R, Mourits MP (1998) Prevalence and management of elevated intraocular pressure in patients with Graves’ orbitopathy. Br J Ophthalmol 82:754–757
Da Silva FLM, de Lourdes Veronese Rodrigues M, Akaishi PMS, Cruz AAV (2009) Graves’ orbitopathy: frequency of ocular hypertension and glaucoma. Eye 23(4):957–959
Konuk O, Onaran Z, Ozhan Oktar S, Yucel C, Unal M (2009) Intraocular pressure and superior ophthalmic vein blood flow velocity in Graves’ orbitopathy: relation with the clinical features. Graefes Arch Clin Exp Ophthalmol 247(11):1555–1559
Mouritz MP, Koornneef L, Wiersinga WM, Prummel MF, Berghout A, van der Gaag R (1989) Clinical criteria for the assessment of disease activity in Graves´ ophthalmopathy: a novel approach. Br J Ophthalmol 73:639–644
Åsman P (2003) Ophthalmological evaluation in thyroid-associated ophthalmopathy. Acta Ophthalmol Scand 81:437–448
Werner SC (1977) Modification of the classification of the eye changes of Graves´ disease: recommendations of the Ad Hoc Commitee of the American Thyroid Association. J Clin Endocrinol Metab 44:203–204
Bartalena L, Baldeschi L, Boboridis K, Eckstein A, Kahaly GJ, Marcocci C, European Group on Graves’ orbitopathy (EUGOGO) (2016) The 2016 European Thyroid Association/European Group on Graves’ Orbitopathy Guidelines for the management of Graves’ orbitopathy. Eur Thyroid J 5(1):9–26
Wiersinga WM, Kahaly GJ (eds) (2010) Graves’ orbitopathy: a multidisciplinary approach-questions and answers, 2nd revised. Karger, Basel, pp 33–39
Fan SX, Zeng P, Li ZJ, Wang J, Liang JQ, Liao YR, Hu YX, Xu MT, Wang M (2021) The clinical features of Graves’ orbitopathy with elevated intraocular pressure. J Ophthalmol 2021:9879503. https://doi.org/10.1155/2021/9879503
Nassr MA, Morris CL, Netland PA, Karcioglu ZA (2009) Intraocular pressure change in orbital disease. Surv Ophthalmol 54(5):519–544
Gumińska M, Goś R, Śmigielski J, Nowak MS (2020) Topical treatment of elevated intraocular pressure in patients with Grave’s orbitopathy. Int J Environ Res Public Health 17:9331
Gharib S, Moazezi Z, Bayani MA (2018) Prevalence and severity of ocular involvement in Graves’ disease according to sex and age: a clinical study from Babol, Iran. Caspian J Intern Med 9(2):178–183
Kuebler AG, Wiecha C, Reznicek L, Klingenstein A, Halfter K, Priglinger S, Hintschich, (2019) Comparison of different devices to measure the intraocular pressure in thyroid-associated orbitopathy. Graefes Arch Clin Exp Ophthalmol 257:2025–2032
Stoyanova NS, Konareva-Kostianeva M, Mitkova-Hristova V, Anglova I (2019) Correlation between intraocular pressure and thickness of extraocular muscles, the severity and activity of thyroid-associated orbitopathy. Folia Med (Plovdiv) 61(1):90–96
Wilinsky RA, Arenson AM, Hurwitz JJ, Szalai J (1984) Ultrasonic B-scan measurement of the extraocular muscles in Graves’ orbitopathy. J Can Assoc Radiol 35:171–173
Fledelius C, Zimmermann-Bielsing T, Feldt-Rasmussen U (2003) Ultrasonically measured horizontal eye muscle thickness in thyroid associated orbitopathy: cross-sectional and longitudinal aspects in a Danish series. Acta Oftalmol Scand 81:143–150
Imbrasienė D, Jankauskienė J, Stanislovaitienė D (2010) Ultrasonic measurement of ocular rectus muscle thickness in patients with Graves’ ophthalmopathy. Medicina (Kaunas) 46:472–476
Karhanova M, Kovar R, Frysak Z, Sin M, Zapletalova J, Rehak J, Herman M (2015) Correlation between magnetic resonance imaging and ultrasound measurements of eye muscle thickness in thyroid-associated orbitopathy. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 159(2):307–312
Spierer A, Eisenstein Z (1991) The role of increased intraocular pressure on upgaze in the assessment of Graves Ophthalmopathy. Ophthalmology 98:1491–1494
Lennerstrand G, Tiam S, Isberg B, Landau Högbeck I, Bolzani R, Tallstedt L, Schworm (2007) Magnetic resonance imaging and ultrasound measurements of extraocular muscles in thyroid-associated ophthalmopathy at different stages of the disease. Acta Ophthalmol Scand 85:192–201
Funding
This work was supported by the Ministry of Health of the Czech Republic–grant no. NU21J-01–00017 and DRO (FNOL, 00098892). All rights reserved.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Ethical approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the Ethics Committee of the University Hospital Olomouc and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.
Consent to participate
Informed consent was obtained from all individual participants included in the study.
Conflict of interest
All authors declare that they have no conflict of interest.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
This article received support from the mentorship team. Further information can be found in the editorial https://link.springer.com/article/10.1007/s00417-019-04518-5
Rights and permissions
About this article
Cite this article
Karhanová, M., Kalitová, J., Kovář, R. et al. Ocular hypertension in patients with active thyroid-associated orbitopathy: a predictor of disease severity, particularly of extraocular muscle enlargement. Graefes Arch Clin Exp Ophthalmol 260, 3977–3984 (2022). https://doi.org/10.1007/s00417-022-05760-0
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00417-022-05760-0